MYC and acute myeloid leukemia: Consistent with the AML cell lines, downregulation of CHK1, WEE1, RAD51, c‐Myc, RRM2, p‐CDC25C, p‐CDK1 and p‐CDK2 was detected in both patient samples (Figure 4A and Figure S2A).